TY - JOUR
T1 - Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N′-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction
AU - Abed, Dhulfiqar Ali
AU - Ali, Ahmed R.
AU - Lee, Sumi
AU - Nguyen, Mai Uyen
AU - Verzi, Michael P.
AU - Hu, Longqin
N1 - Funding Information:
We would like to thank the Center for Integrative Proteomics Research (CIPR) at Rutgers University for conducting HRMS measurements. This work was supported in part by the National Cancer Institute [ R01CA133791 ] and the Rutgers TechAdvance Grant [ TA2019-0300 ].
Funding Information:
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Longqin Hu reports financial support was provided by National Institutes of Health. Longqin Hu reports financial support was provided by Rutgers The State University of New Jersey. Longqin Hu reports a relationship with Rutgers The State University of New Jersey that includes: employment. Michael P. Verzi reports a relationship with Rutgers The State University of New Jersey that includes: employment. Dhulfiqar Ali Abed reports a relationship with Rutgers The State University of New Jersey that includes: employment. Ahmed R. Ali reports a relationship with Rutgers The State University of New Jersey that includes: employment. Sumi Lee reports a relationship with Rutgers The State University of New Jersey that includes: employment. Mai-Uyen Nguyen reports a relationship with Rutgers The State University of New Jersey that includes: employment. Longqin Hu has patent #Small Molecule Direct Inhibitors of Keap1-Nrf2 Protein-Protein Interaction pending to Rutgers The State University of New Jersey. Dhulfiqar Ali Abed has patent #Small Molecule Direct Inhibitors of Keap1-Nrf2 Protein-Protein Interaction pending to Rutgers The State University of New Jersey. Ahmed R. Ali has patent #Small Molecule Direct Inhibitors of Keap1-Nrf2 Protein-Protein Interaction pending to Rutgers The State University of New Jersey.We would like to thank the Center for Integrative Proteomics Research (CIPR) at Rutgers University for conducting HRMS measurements. This work was supported in part by the National Cancer Institute [R01CA133791] and the Rutgers TechAdvance Grant [TA2019-0300].
Publisher Copyright:
© 2023 Elsevier Masson SAS
PY - 2023/4/5
Y1 - 2023/4/5
N2 - Direct inhibition of the protein-protein interaction (PPI) between Kelch-like ECH-associated protein 1 (Keap1) and nuclear factor erythroid 2-related factor 2 (Nrf2) reduces the ubiquitination and subsequent degradation of Nrf2, leading to Nrf2 accumulation in the cytosol and the nuclear translocation of Nrf2. Once inside the nucleus, Nrf2 binds to and activates the expression of antioxidant response element (ARE) genes involved in redox homeostasis and detoxification. Herein, we report a series of 1,4-bis(arylsulfonamido)naphthalene-N,N′-diacetic acid analogs with varying C2 substituents to explore the structure-activity relationships at this position of the central naphthalene core. The Keap1-binding activities were first screened with a fluorescence polarization (FP) assay followed by further evaluation of the more potent compounds using a more sensitive time-resolved fluorescence energy transfer (TR-FRET) assay. It was found that compound 24a with C2-phthalimidopropyl group was the most potent in this series showing an IC50 of 2.5 nM in the TR-FRET assay with a Ki value in the subnanomolar range. Our docking study indicated that the C2-phthalimidopropyl group in compound 24a provided an extra hydrogen bonding interaction with the key residue Arg415 that may be responsible for the observed boost in binding affinity. In addition, compounds 12b, 15, and 24a were shown to activate the Nrf2 signaling pathway in NCM460D cells resulting in elevated mRNA levels of GSTM3, HMOX1 and NQO1 by 2.4–11.7 fold at 100 μM as compared to the vehicle control.
AB - Direct inhibition of the protein-protein interaction (PPI) between Kelch-like ECH-associated protein 1 (Keap1) and nuclear factor erythroid 2-related factor 2 (Nrf2) reduces the ubiquitination and subsequent degradation of Nrf2, leading to Nrf2 accumulation in the cytosol and the nuclear translocation of Nrf2. Once inside the nucleus, Nrf2 binds to and activates the expression of antioxidant response element (ARE) genes involved in redox homeostasis and detoxification. Herein, we report a series of 1,4-bis(arylsulfonamido)naphthalene-N,N′-diacetic acid analogs with varying C2 substituents to explore the structure-activity relationships at this position of the central naphthalene core. The Keap1-binding activities were first screened with a fluorescence polarization (FP) assay followed by further evaluation of the more potent compounds using a more sensitive time-resolved fluorescence energy transfer (TR-FRET) assay. It was found that compound 24a with C2-phthalimidopropyl group was the most potent in this series showing an IC50 of 2.5 nM in the TR-FRET assay with a Ki value in the subnanomolar range. Our docking study indicated that the C2-phthalimidopropyl group in compound 24a provided an extra hydrogen bonding interaction with the key residue Arg415 that may be responsible for the observed boost in binding affinity. In addition, compounds 12b, 15, and 24a were shown to activate the Nrf2 signaling pathway in NCM460D cells resulting in elevated mRNA levels of GSTM3, HMOX1 and NQO1 by 2.4–11.7 fold at 100 μM as compared to the vehicle control.
KW - C-2 naphthalene derivatives
KW - Fluorescence polarization
KW - Keap1
KW - Keap1-Nrf2 interaction
KW - Nrf2
KW - Protein-protein interaction inhibitor
KW - Structure-activity relationship
KW - TR-FRET
UR - http://www.scopus.com/inward/record.url?scp=85150926645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150926645&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2023.115302
DO - 10.1016/j.ejmech.2023.115302
M3 - Article
C2 - 36989811
AN - SCOPUS:85150926645
SN - 0223-5234
VL - 252
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
M1 - 115302
ER -